APPARATUS AND METHODS FOR TREATING PULMONARY CONDITIONS

• US 20080183248A1
• Filed: 01/17/2008
• Published: 07/31/2008
• Est. Priority Date: 01/17/2007
• Status: Abandoned Application

• Current Assignee: Cleveland Clinic Foundation
• Original Assignee: Cleveland Clinic Foundation
• Inventors: Ansarina, Medhi, Rezai, Ali R., Deogaonkar, Milind
• Application Number:
  US12/016,127
• Publication Number:
  US 20080183248A1
• Time in Patent Office: Days
• US Class Current: 607/62
• CPC Class Codes: A61N 1/0553 Paddle shaped electrodes, e.g. for laminotomy
• CPC Class Codes: A61N 1/0556 Cuff electrodes
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362

Abstract

An endotracheal apparatus includes a stent member including first and second ends and a lumen extending between the ends. The lumen defines an inner surface opposite an outer surface. The apparatus also includes an electrode assembly operably coupled to the stent member. The electrode assembly includes a flexible member having first and second end portions and oppositely disposed first and second surfaces, at least one electrode is operably connected to a portion of at least one of the first or second surfaces, and an attachment mechanism for securing the at least one electrode to at least one of the first or second surfaces. The at least one electrode is adapted to selectively deliver electric current to the target site and effect a change in the autonomic nervous system of the subject.

Claims

1. An endotracheal apparatus for treating a pulmonary condition, said apparatus comprising:

a stent member including first and second ends and a lumen extending between said ends, said lumen defining an inner surface opposite an outer surface; and

an electrode assembly operably coupled to said stent member, said electrode assembly comprising a flexible member having first and second end portions and oppositely disposed first and second surfaces, at least one electrode operably connected to a portion of at least one of said first or second surfaces, and an attachment mechanism for securing said at least one electrode to at least one of said first or second surfaces, said at least one electrode being adapted to selectively deliver electric current to the target site and effect a change in the autonomic nervous system (ANS) of the subject.

2. The endotracheal apparatus of claim 1, wherein said second surface of said flexible member is operably coupled to said inner surface of said stent member.

3. The endotracheal apparatus of claim 1, wherein said first surface of said flexible member is operably coupled to said outer surface of said stent member.

4. The endotracheal apparatus of claim 1, wherein said stent member has a cylinder-shaped configuration.

5. The endotracheal apparatus of claim 1, wherein said stent member has a Y-shaped configuration.

6. The endotracheal apparatus of claim 1, wherein said stent member is adapted to conform to an inner surface of the tracheo-bronchial tree.

7. The endotracheal apparatus of claim 1, wherein said flexible member has a C-shaped configuration.

8. The endotracheal apparatus of claim 1, wherein said at least one electrode extends across a portion of said flexible member.

9. The endotracheal apparatus of claim 1, wherein said at least one electrode extends across the entire portion of said flexible member.

10. The endotracheal apparatus of claim 1, wherein electric current is delivered to said at least one electrode via a wireless energy source.

11. The endotracheal apparatus of claim 1, wherein said attachment mechanism comprises a metal member and a plurality of securing members, said metal member being operably coupled to at least one of said first or second surfaces of said flexible member via said securing members.

12. The endotracheal apparatus of claim 1, wherein at least a portion of said electrode assembly is treated with a therapeutic agent for eluting into vascular tissue, the blood stream, or a combination thereof.

13. The endotracheal apparatus of claim 12, wherein a plurality of portions of said electrode assembly are separately treated with a different one of said at least one therapeutic agent.

14. The endotracheal apparatus of claim 1, wherein at least a portion of said electrode assembly is covered with a layer of biocompatible material.

15. The endotracheal apparatus of claim 1, wherein a sensor capable of sensing a bodily activity associated with the pulmonary condition is associated with said electrode assembly.

16. The endotracheal apparatus of claim 15, wherein said sensor is operably coupled to a portion of said electrode assembly.

17. The endotracheal apparatus of claim 1, the pulmonary disorder being selected from the group consisting of genetic conditions, acquired conditions, primary conditions, secondary conditions, asthma, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, pneumonia, bronchitis, emphysema, adult respiratory distress syndrome, allergies, lung cancer, small cell lung cancer, primary lung cancer, metastatic lung cancer, bronchiectasis, bronchopulmonary dysplasia, chronic bronchitis, chronic lower respiratory diseases, croup, high altitude pulmonary edema, pulmonary fibrosis, interstitial lung disease, reactive airway disease, lymphangioleiomyomatosis, neonatal respiratory distress syndrome, parainfluenza, pleural effusion, pleurisy, pneumothorax, primary pulmonary hypertension, psittacosis, pulmonary edema secondary to various causes, pulmonary embolism, pulmonary hypertension secondary to various causes, respiratory failure secondary to various causes, sleep apnea, sarcoidosis, smoking, stridor, acute respiratory distress syndrome, infectious diseases, SARS, tuberculosis, psittacosis infection, Q fever, parainfluenza, respiratory syncytial virus, combinations thereof, and conditions caused by any one or combination of the above.

18. The endotracheal apparatus of claim 1, wherein the at least one nerve is selected from the group consisting of an esophageal plexus, a cardiac plexus, a pulmonary plexus, an anterior pulmonary plexus, and a posterior pulmonary plexus.

27. The method of claim 1, wherein delivery of electric current to the anterior pulmonary plexus effects a change in both the SNS and the PNS.

28. The method of claim 1, wherein delivery of electric current to the posterior pulmonary plexus effects a change in both the SNS and the PNS.

19. A method for treating a pulmonary condition in a subject, said method comprising the steps of:

providing a stent member and an electrode assembly operably coupled to the stent member, the stent member including first and second ends and a lumen extending between the ends, the lumen defining an inner surface opposite an outer surface, the electrode assembly comprising a flexible member, at least one electrode operably secured to the flexible member, and an attachment mechanism for securing the at least one electrode to the flexible member;

implanting the endotracheal apparatus at a target site in the tracheo-bronchial tree of the subject, the target site being innervated by at least one nerve of the ANS;

positioning the endotracheal device such that a portion of the at least one electrode is substantially adjacent the target site; and

delivering electric current to the at least one electrode to effect a change in the ANS of the subject.

20. The method of claim 19, wherein delivery of electric current to the at least one electrode effects a change in the parasympathetic nervous system (PNS) of the subject.

21. The method of claim 19, wherein delivery of electric current to the at least one electrode effects a change in the sympathetic nervous system (SNS) of the subject.

22. The method of claim 19, wherein the at least one nerve is selected from the group consisting of an esophageal plexus, a cardiac plexus, a pulmonary plexus, an anterior pulmonary plexus, and a posterior pulmonary plexus.

23. The method of claim 19, wherein electric current is delivered to the anterior pulmonary plexus to effect a change in the SNS of the subject.

24. The method of claim 19, wherein electric current is delivered to the posterior pulmonary plexus to effect a change in the PNS of the subject.

25. The method of claim 19 further comprising the steps of:

sensing a bodily activity associated with the pulmonary condition;

generating a sensor signal based on the bodily activity; and

activating the electrode assembly to adjust application of electric current to the target site in response to the sensor signal to treat the pulmonary condition.

26. The method of claim 19, wherein the pulmonary condition is selected from the group consisting of genetic conditions, acquired conditions, primary conditions, secondary conditions, asthma, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, pneumonia, bronchitis, emphysema, adult respiratory distress syndrome, allergies, lung cancer, small cell lung cancer, primary lung cancer, metastatic lung cancer, bronchiectasis, bronchopulmonary dysplasia, chronic bronchitis, chronic lower respiratory diseases, croup, high altitude pulmonary edema, pulmonary fibrosis, interstitial lung disease, reactive airway disease, lymphangioleiomyomatosis, neonatal respiratory distress syndrome, parainfluenza, pleural effusion, pleurisy, pneumothorax, primary pulmonary hypertension, psittacosis, pulmonary edema secondary to various causes, pulmonary embolism, pulmonary hypertension secondary to various causes, respiratory failure secondary to various causes, sleep apnea, sarcoidosis, smoking, stridor, acute respiratory distress syndrome, infectious diseases, SARS, tuberculosis, psittacosis infection, Q fever, parainfluenza, respiratory syncytial virus, combinations thereof, and conditions caused by any one or combination of the above.